Chinese firm to conduct COVID treatment trial in PH

  • 📰 ANCALERTS
  • ⏱ Reading Time:
  • 50 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 50%

Philippines Headlines News

Philippines Latest News,Philippines Headlines

DOH: Chinese biotech firm to conduct COVID19 treatment trial in PH

MANILA—A Chinese biotech firm is planning to conduct a clinical trial in the Philippines for its experimental prostate cancer drug as treatment against COVID-19 infection, the Department of Health disclosed Friday.

The drug called proxalutamide, which is developed by Kintor Pharmaceuticals, is a nonsteroidal antiandrogen originally conceived for the treatment of prostate and breast cancer, Health Undersecretary Maria Rosario Vergeire said. "Meron na pong nakasalang na magiging trial dito sa atin sa Pilipinas and they have identified the Lung Center of the Philippines for this. They are currently processing the contract," she said in a press briefing.Kintor previously touted a Brazilian study of proxalutamide, which claimed a high effectiveness rate.

The Brazil study said proxalutamide showed a 92 perent reduction in mortality risk among hospitalized COVID-19 patients.The Brazil study of the drug has not been peer-reviewed or published, but the authors released a short presentation of its results during a March news conference. One of the study's authors, Brown University dermatology professor Carlos Wambier, called its results "very encouraging."

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Patay Tayo Dyan’ Ginawang Guinea Pig ang Pinoy

Start with Duterte, para deads agad...

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 26. in PH

Philippines Latest News, Philippines Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Chinese firm to start trials of COVID drug proxalutamide in PH in NovemberChinese biotech firm Kintor Pharmaceutical Limited plans to conduct clinical trials in the Philippines for its experimental drug for COVID-19 called proxalutamide that is also being developed to treat prostate and breast cancer, DOH said. | cgonzalesINQ
Source: inquirerdotnet - 🏆 3. / 86 Read more »

PH ‘too focused narrowly’ on COVID—NEDAThe National Economic and Development Authority (NEDA) said the government failed to balance its response to the coronavirus disease with the need of equally salvaging the economy from the pandemic-induced crisis. Oh they salvaged Filipinos alright.
Source: manilabulletin - 🏆 25. / 51 Read more »

PH begins COVID vaccination of children with comorbiditiesThe Philippines on Friday began the vaccination of children aged 12 to 17 with health risks in an expansion of its jab coverage against COVID-19.
Source: ANCALERTS - 🏆 26. / 50 Read more »

PH planning additional COVID shot for immunocompromisedThe Philippines is planning of giving an additional dose of COVID-19 vaccine to immunocompromised people due to higher risk of breakthrough infection.
Source: ABSCBNNews - 🏆 5. / 83 Read more »

DOH says 12,686 COVID-19 vaccine doses wastedMANILA, Philippines — Over 12,500 of the total 87 million COVID-19 vaccine doses so far received by the country have been wasted, an official of the Department of Health (DOH) revealed
Source: inquirerdotnet - 🏆 3. / 86 Read more »

Gatchalian to COVID-19 task force: Don’t allow walk-ins in vaccination for minorsSenator Sherwin Gatchalian has appealed to the National Task Force Against COVID-19 not to allow “walk-ins” during the roll out of its vaccination program for minors on Friday, October 15.
Source: manilabulletin - 🏆 25. / 51 Read more »